Anavatos Bio Inc.
Biotech · Regulation D 506(b) · WA · Filed July 20, 2026
View all SEC Form D filings for Anavatos Bio Inc.- Offering amount
- Undisclosed
- Exemption
- Reg D 506(b)
- Issuer state
- WA
- Filing date
- July 20, 2026
- Signature date
- July 20, 2026
- CIK
- 0002067551
What is a Form D filing?
A Form D is the notice a private company files with the U.S. Securities and Exchange Commission when raising capital through an offering exempt under Regulation D (Rule 506(b), 506(c), or 504). It discloses the offering but is not a solicitation, an endorsement, or a statement of investment merit. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.
Public filing directories
Browse directories that group public SEC Form D records by the same filing tags shown on this page. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.
Filing snapshot
Anavatos Bio Inc. (based in WA) filed SEC Form D/A on July 20, 2026, disclosing an offering of securities (amount not disclosed) under Rule 506(b) of Regulation D. FormDFlow has tagged the issuer's sector as Biotech. This page reflects the public filing as recorded in SEC EDGAR; see the source document for the complete disclosure.
FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.
Source
FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.